Oxidative stress, body fat composition, and endocrine status in pre- and postmenopausal women

Menopause

Volumn 15, Issue 1, 2008, Pages 112-118

  Pansini, Francesco ^a,d   Cervellati, Carlo ^a   Guariento, Angela ^a   Stacchini, Maria Antonella ^b   Castaldini, Cristina ^a   Bernardi, Andrea ^a   Pascale, Giuliana ^a   Bonaccorsi, Gloria ^a   Patella, Alfredo ^a   Bagni, Bruno ^c   Mollica, Gioacchino ^a   Bergamini, Carlo M ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b San Marino State Hospital   (San Marino)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d Centro di Ricerca e Servizio   (Italy)

Author keywords

Age; Antioxidant defense; Body mass composition; Menopause; Oxidative stress

Indexed keywords

HYDROPEROXIDE;

ABDOMINAL FAT; ADULT; AGING; ANALYSIS OF COVARIANCE; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; CLIMACTERIUM; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INTRAABDOMINAL FAT; LIPID COMPOSITION; MENOPAUSE; OXIDATIVE STRESS; POSTMENOPAUSE; PREMENOPAUSE; STATISTICAL SIGNIFICANCE;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADULT; ANTIOXIDANTS; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS INDEX; BODY WEIGHT; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; ITALY; MIDDLE AGED; OXIDATIVE STRESS; POSTMENOPAUSE; PREMENOPAUSE; REGRESSION ANALYSIS; WOMEN'S HEALTH;

EID: 38049014431     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318068b285     Document Type: Article

References (48)

1. Pansini F, Mollica G, Bergamini CM. Management of the menopausal disturbances and oxidative stress. Curr Pharm Des 2005;11:2063-2073.
2. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977;4:21-48.
3. de Aloysio D, Fabiani AG, Mauloni M, et al. Analysis of the climacteric syndrome. Maturitas 1989;11:43-53.
4. Van Voorhis BJ. Genitourinary symptoms in the menopausal transition. Am J Med 2005;118:47-53.
5. Larson B, Collins A, Landgren BM. Urogenital and vasomotor symptoms in relation to menopausal status and the use of hormone replacement therapy (HRT) in healthy women during transition to menopause. Maturitas 1997;28:99-105.
6. Sherman S. Defining the menopausal transition. Am J Med 2005;118:3-7.
7. Delaney MF. Strategies for the prevention and treatment of osteoporosis during early postmenopause. Am J Obstet Gynecol 2006;194:S12-S23.
8. Colditz GA, Willet WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-1110.
9. Witteman JCM, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. BMJ 1989;298:642-644.
10. Guthrie JR, Taffe JR, Lehert P, Burger HG, Dennerstein L. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause 2004;11:315-322.
11. Harman SM, Brinton EA, Clarkson T, et al. Is the WHI relevant to HRT started in the perimenopause? Endocrine 2004;24:195-202.
12. Rebuffe-Scrive M, Eldh J, Hafstrom LO, Bjorntorp P. Metabolism of mammary, abdominal and femoral adipocytes in women before and after menopause. Metabolism 1986;35:792-797.
13. Rebuffe-Scrive M, Lonnroth P, Marin P, Wesslau C, Bjorntorp P, Smith U. Regional adipose tissue metabolism in men and postmenopausal women. Int J Obes 1987;11:347-355.
14. Young CM, Blonding J, Tensuan R, et al. Body composition study of older women, thirty to seventy years of age. Ann N Y Acad Sci 1963;110:589-607.
15. Ley C, Less B, Stevenson J. Sex and menopause associated change in body fat distribution. Am J Clin Nutr 1992;55:950-954.
16. Svendsen OL, Hassager C, Christiansen C. Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 1995;44:369-373.
17. Trémollieres FA, Pouilles JM, Ribot CA. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol 1996;17:1594-1600.
18. Simkin-Silverman LR, Wing RR. Weight gain during menopause. Postgrad Med 2000;108:47-50, 53-54, 56.
19. Hwo CM, Fuh JL, Hsiao CF, et al. Waist circumference predicts metabolic cardiovascular risk in postmenopausal Chinese women. Menopause 2003;10:73-80.
20. Despres J-P. The insulin resistance-dyslipidemic syndrome of visceral adiposity: effect on patients' risk. Obes Res 1998;6(Suppl 1):8S-17S.
21. Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269-270.
22. Telci A, Cakatay U, Akhan SE, Bilgin ME, Turfanda A, Sivas A. Postmenopausal hormone replacement therapy use decreases oxidative protein damage. Gynecol Obstet Invest 2002;54:88-93.
23. Rontu R, Solakivi T, Teisala K, Lehtimaki T, Punnonen R, Jokela H. Impact of long-term hormone replacement therapy on in vivo and in vitro markers of lipid oxidation. Free Radic Res 2004;38:129-137.
24. Bergamini CM, Gambetti S, Dondi A, Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 2004;10:1611-1626.
25. Olui SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002;26:1159-1164.
26. Chrysohoou C, Panagiotakos DB, Pitsavos C, et al. The implication of obesity in apparently healthy men and women: the ATTICA study [E-pub]. Nutr Metab Cardiovasc Dis 2006.
27. Reckelhoff JF, Fortepiani LA. Novel mechanism responsible for postmenopausal hypertension. Hypertension 2004;43:918-925.
28. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Menopause 2001;8:402-407.
29. den Tonkelaar I, Broekmans FJ, de Boer EJ, te Velde ER. Letter to the editor. Menopause 2002;6:463-465.
30. Cesarone MR, Belcaro G, Carratelli M, et al. A simple test to monitor oxidative stress. Int Angiol 1999;18:127-130.
31. Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999;299:15-27.
32. Sitruk-Ware R, Utian WH. The Menopause and Hormonal Replacement Therapy. Facts and Controversies. New York, NY: Marcel Dekker, 1991.
33. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 2006;116:1186-1194.
34. Wilson AM, Ryan MC, Boyle AJ. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol 2006;106:291-297.
35. Miller AP, Chen YF, Xing D, Feng W, Oparil S. Hormone replacement therapy and inflammation: interactions in cardiovascular disease. Hypertension 2003;42:657-663.
36. Kanaley JA, Sames C, Swisher L, et al. Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism 2001;50:976-982.
37. Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B. Estrogen controls lipolysis by up-regulating α2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor α. Implications for the female fat distribution. J Clin Endocrinol Metab 2004;89:1869-1878.
38. Francucci CM, Daniele P, Iori N, Camilletti A, Massi F, Boscaro MJ. Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women. J Endocrinol Invest 2005;28:623-631.
39. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995;123:673-675.
40. Poehlman ET. Notice of retraction: final resolution. Ann Intern Med 2005;142:798.
41. Gambacciani M, Ciaponi M, Cappagli B, et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 1997;82:414-417.
42. Douchi T, Yamamoto S, Yoshimitsu N, Andoh T, Matsuo T, Nagata Y. Relative contribution of aging and menopause to changes in lean and fat mass in segmental regions. Maturitas 2002;42:301-306.
43. Simpson E, Jones M, Misso M, et al. Estrogen, a fundamental player in energy homeostasis. J Steroid Biochem 2005;95:3-8.
44. Chen J-Q, Yager JD, Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta 2005;1746:1-17.
45. Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K. Macrophage-secreted factors impair human adipogenesis. Involvement of proinflammatory state in preadipocytes. Endocrinology 2007;148:868-877.
46. Michos C, Kiortsis DN, Evangelou A, Karkabounas S. Antioxidant protection during the menstrual cycle: the effects of estradiol on ascorbic- dehydroascorbic acid plasma levels and total antioxidant plasma status in eumenorrhoic women during the menstrual cycle. Acta Obstet Gynecol Scand 2006;85:960-965.
47. Santo Signorelli S, Nerib S, Sciacchitano S, et al. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 2006;53:77-82.
48. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005;3:28.